Adisun Pharma Private Limited
About Adisun Pharma Private Limited
Data last updated:
Adisun Pharma Private Limited is a private limited company based in Satara, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC168229. Its GSTIN is 27AAPCA1083R1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinayak Mangeni Lawate and Dattatray Bhiva Lawate.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Satara, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.13 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹6.85 Lakh (net margin 3.2%) and EBITDA of ₹9.1 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adisun Pharma Private Limited's registered office is in Satara, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.1 Sadanand Dham Nishigandha Colony, Samarth Nagar, Satara, Maharashtra, India – 415002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Adisun Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adisun Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adisun Pharma Private Limited, buy the company report.
Financials of Adisun Pharma Private Limited
FY 2025 filings availableAdisun Pharma Private Limited reported revenue of ₹2.13 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 22% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adisun Pharma Private Limited, buy the company report.
Board of directors of Adisun Pharma Private Limited
Adisun Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinayak Mangeni Lawate | Director | 03 Feb 2017 | 9 Years 8 Months | Current |
| Dattatray Bhiva Lawate | Director | 03 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
Adisun Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Granvalor Pharmaceuticals Private Limited | ₹2.14 Cr (FY 2025) | 22.0% | Hyderabad, Telangana, India | |||
| Dean Formulations Private Limited | ₹2.14 Cr (FY 2024) | 65.0% | Chennai, Tamil Nadu, India | |||
| Adisun Pharma Private Limitedthis company | ₹2.13 Cr (FY 2025) | ₹6.85 Lakh | 3.2% | 22.0% | Satara, Maharashtra, India | |
| Adenscot Healthcare Private Limited | ₹2.12 Cr (FY 2025) | -66.0% | Yamuna Nagar, Haryana, India |
To see the full peer comparison of Adisun Pharma Private Limited, buy the company report.
Auditor
Adisun Pharma Private Limited is audited by UTTAM D BANKAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UTTAM D BANKAR & CO | FY 2021 | 121072W |
Shareholding
The shareholding of Adisun Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Adisun Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adisun Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adisun Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adisun Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA1083R1ZZ | Maharashtra | Active | 25 Jul 2017 |
To see the full GST registrations and return filing status of Adisun Pharma Private Limited, buy the company report.
Recent activity
Adisun Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Babaso Maruti Doltade ceased to be Director on 01 Oct 2022.
Frequently asked questions
Adisun Pharma is an active private limited company based in Satara, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2017 (9+ years old) and is registered under CIN U74999PN2017PTC168229.
Adisun Pharma has 2 current directors:
- Vinayak Mangeni Lawate - Director
- Dattatray Bhiva Lawate - Director
The latest financial statements of Adisun Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Adisun Pharma is 27AAPCA1083R1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Adisun Pharma is U74999PN2017PTC168229. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adisun Pharma was incorporated on 03 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Adisun Pharma by revenue are Granvalor Pharmaceuticals Private Limited, Dean Formulations Private Limited, Adenscot Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Babaso Maruti Doltade ceased to be Director on 01 Oct 2022. Dattatray Bhiva Lawate was appointed as Director on 03 Feb 2017. Vinayak Mangeni Lawate was appointed as Director on 03 Feb 2017.
The registered office of Adisun Pharma is at Plot No.1 Sadanand Dham Nishigandha Colony, Samarth Nagar, Satara, Maharashtra, India – 415002.
Adisun Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Adisun Pharma is compliant as of 30 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
